Core Scientific (CORZ) Cash & Current Investments (2021 - 2026)

Core Scientific has disclosed Cash & Current Investments across 6 years of filings, most recently posting $1.9 billion for Q2 2026.

• In Q2 2026, Cash & Current Investments rose 232.93% year-over-year to $1.9 billion; the TTM figure through Jun 2026 stood at $1.9 billion (up 232.93% YoY), while the FY2025 annual figure was $311.4 million, down 62.8% from the prior year.
• Cash & Current Investments came in at $1.9 billion for Q2 2026 at Core Scientific, up from $1.1 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1.9 billion in Q2 2026 to a low of $52.2 million in Q4 2022.
• Average Cash & Current Investments over 5 years is $415.4 million, with a median of $274.0 million recorded in 2022.
• Year-over-year, Cash & Current Investments surged 18181.06% in 2022 and sank 81.54% in 2023.
• Over 5 years, Cash & Current Investments stood at $52.2 million in 2022, then soared by 33.44% to $69.7 million in 2023, then soared by 1100.68% to $837.0 million in 2024, then plunged by 62.8% to $311.4 million in 2025, then jumped by 521.59% to $1.9 billion in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $1.9 billion in Q2 2026, $1.1 billion in Q1 2026, and $311.4 million in Q4 2025.